Drug Profile
NSC 375575
Alternative Names: CPEC; CyclopentenylcytosineLatest Information Update: 26 Aug 2002
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA)
- Class Antineoplastics; Antivirals; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Cytidine triphosphate synthetase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer